For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Denali Therapeutics Inc.

USPTO Granted Patents = 57

EPO Patents = 11

Trademarks = 3

Forward Citations = 131

Loading Chart...

Loading Chart...

84 inventors (with patents filed for the assignee):

Jianwen A Feng (28 out of 34 patents)

Javier De Vicente Fidalgo (27 out of 35 patents)

Anthony A Estrada (27 out of 53 patents)

4. Zachary Kevin Sweeney (25 out of 76 patents)

5. Brian M Fox (16 out of 25 patents)

6. Joseph P Lyssikatos (14 out of 141 patents)

7. Maksim Osipov (12 out of 24 patents)

8. Mihalis S Kariolis (12 out of 12 patents)

9. Adam P Silverman (10 out of 13 patents)

10. Anantha R Sudhakar (10 out of 48 patents)

11. Mark S Dennis (9 out of 101 patents)

12. Colin Philip Leslie (8 out of 13 patents)

13. Travis Remarchuk (7 out of 15 patents)

14. Arun Thottumkara (7 out of 7 patents)

15. Cathal S Mahon (7 out of 7 patents)

Core Competencies:

Fusion Proteins

Kinase Inhibitors

Anti-TREM2 Antibodies

LRRK2 Inhibitors

Transferrin Receptor

Protein Molecules

Eukaryotic Initiation Factor

Pyrimidinyl Compounds

Enzyme Replacement Therapy

Polypeptides

Oxadiazine Compounds

Morpholinopyrimidines

57 patents: Sort by Forward Citations

1. 12747232 - Compounds, compositions, and methods (2026-09-29),

2. 12703761 - ANTI-HER2 ANTIBODIES AND METHODS OF USE THEREOF (2026-08-11),

3. 12667606 - FORMULATIONS OF PROTEIN MOLECULES COMPRISING IDURONATE 2-SULFATASE (2026-06-30),

4. 12662458 - Solid forms of a compound (2026-06-23),

5. 12636363 - ANTI-TRANSFERRIN RECEPTOR FUSION PROTEINS AND METHODS OF USE THEREOF (2026-05-26),

6. 12497387 - Process for the preparation of pyrimidinyl-4-aminopyrazole compounds (2025-12-16),

7. 12378540 - Fusion proteins comprising acid alpha-glucosidase enzymes and methods thereof (2025-08-05),

8. 12358928 - Compounds, compositions and methods (2025-07-15),

9. 12358896 - LRRK2 inhibitors and methods of making and using thereof (2025-07-15),

10. 12240902 - Anti-TREM2 antibodies and methods of use thereof (2025-03-04),

11. 12180211 - Compounds, compositions and methods (2024-12-31),

12. 12162948 - Methods of engineering transferrin receptor binding polypeptides (2024-12-10),

13. 12139478 - Compounds, compositions and methods (2024-11-12),

14. 12129263 - Kinase inhibitors and uses thereof (2024-10-29),

15. 12091392 - Compounds, compositions and methods (2024-09-17),

Company Overview

Denali Therapeutics Inc., based in South San Francisco, specializes in the development of innovative biopharmaceuticals aimed at treating neurodegenerative diseases. The company focuses on advanced therapeutic modalities, including fusion proteins and kinase inhibitors, to target critical pathways involved in neurological disorders. Denali's research encompasses a range of core technologies, such as anti-TREM2 antibodies and LRRK2 inhibitors, positioning it at the forefront of therapeutic innovation in the biopharmaceutical sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

57 Patents

#25 in South San Francisco, CA

#1,463 in California

#6,244 in US

#12,552 in the World

South San Francisco, CA, United States of America

Denali Therapeutics Inc.

Forward Citations = 131

84 inventors:

Jianwen A Feng (28 out of 34 patents)

Javier De Vicente Fidalgo (27 out of 35 patents)

Anthony A Estrada (27 out of 53 patents)

4. Zachary Kevin Sweeney (25 out of 76 patents)

5. Brian M Fox (16 out of 25 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Denali Therapeutics Inc.. Retrieved from https://idiyas.com/company/denali-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…